Share:
House Co-Sponsorship Memoranda
House of Representatives
Session of 2023 - 2024
Regular Session
MEMORANDUM
| Posted: | November 25, 2024 01:20 PM |
|---|---|
| From: | Representative Dan Frankel |
| To: | All House members |
| Subject: | Pharmaceutical Affordability Board Act |
| Almost 3 in 10 Americans reported in a 2022 Kaiser Family Foundation Survey that they had skipped doses of needed medication because of cost. More than 8 in 10 adults say the cost of prescription drugs is unreasonable. And almost 9 out of 10 adults believe we should limit how much drug companies can increase prices each year. These numbers speak for themselves. Pennsylvania must follow the lead of the federal government and take action to control the costs of medication. Prescription drugs, like electricity, home heating, and clean water, are fundamental necessities for our residents. We must make sure they are available and affordable. Drawing on lessons from existing programs in Colorado and Maryland, I will soon reintroduce legislation to create a Prescription Drug Affordability Board. Under my legislation, the board would be empowered to review the costs of medications and the financial burdens they create and establish an upper payment limit for how much Pennsylvanians would be asked to pay for their prescription drugs -- much like the “maximum fair price” review for medication paid for by Medicare. I invite you to join me in this meaningful, tested approach to tackle rising prescription drug costs by co-sponsoring the “Pharmaceutical Affordability Board Act.” |
Memo Updated: December 2, 2024 09:07 AM